SOX17 and pulmonary arterial hypertension: To further examine the potential effect of common variation in the enhancer area on downstream targets of SOX17, we analysed the plasma proteome of 431 PAH patients with a known genotype of the SOX17-signal 1 and SOX17-signal 2 using linear regression analysis.